| Literature DB >> 29581998 |
Gabriel Hundeshagen1,2,3, David N Herndon1,2, Robert P Clayton1,2, Paul Wurzer4, Alexis McQuitty5, Kristofer Jennings6, Ludwik Branski1,2,4, Vanessa N Collins2, Nicole Ribeiro Marques5, Celeste C Finnerty1,2, Oscar E Suman1,2, Michael P Kinsky4.
Abstract
BACKGROUND: Sepsis, trauma, and burn injury acutely depress systolic and diastolic cardiac function; data on long-term cardiac sequelae of pediatric critical illness are sparse. This study evaluated long-term systolic and diastolic function, myocardial fibrosis, and exercise tolerance in survivors of severe pediatric burn injury.Entities:
Year: 2017 PMID: 29581998 PMCID: PMC5865217 DOI: 10.1016/S2352-4642(17)30122-0
Source DB: PubMed Journal: Lancet Child Adolesc Health ISSN: 2352-4642
Study subject characteristics
| Characteristic | Postburn (N = 40) | Healthy Control (N = 25) | p |
|---|---|---|---|
| Age at study (years) | 19±5 | 21±3 | ns |
| Age at burn (years) | 8±5 | – | – |
| Years post burn | 12±4 | – | – |
| Sex (male/female) | 23/17 | 11/14 | ns |
| Ethnicity | |||
| Hispanic – Latino | 36 (90) | 5 | < 0.0001 |
| White American | 4 (10) | 10 | |
| African American/Asian | 0 (0) | 8 | |
| BMI (kg/m2) | 24±4 | 23±5 | ns |
| TBSA burned (%) | 59±19 | – | – |
| Baux score | 74±25 | – | – |
| Cause of burn | |||
| Flame | 30 (75) | – | – |
| Scald | 5 (12.5) | – | – |
| Electrical injury | 5 (12.5) | – | – |
| DA (days) | 6±8 | – | – |
| LOH (days) | 39±29 | – | – |
| Inhalation injury | 16 (40) | – | – |
| Days on mechanical ventilation | 12±23 | – | – |
| Acute operations | 6±5 | – | – |
| Sepsis | 9 (23) | – | – |
| Inotrope medication administered | 14 (35) | ||
| Dobutamine | 10 (25) | – | – |
| Epinephrine | 2 (5) | – | – |
| Dopamine | 1 (2.5) | – | – |
| Milrinone | 1 (2.5) | – | – |
Data reported as mean ± SD unless or n (%) unless otherwise noted.
BMI = Body mass index. Baux score = patient age + TBSA burned + 17 (if inhalation injury present). TBSA = total body surface area. DA = delay of admission (days from burn to admission). LOH = length of acute hospitalization (days).
Echocardiographic results
| Measurement | Postburn | Healthy Control | p |
|---|---|---|---|
| Systolic function | |||
| EF, % | 52 ± 9.1 | 61 ± 6.1 | 0.004 |
| EF < 50% | 11 (28) | 0 (0) | |
| EF < 40% | 6 (15) | 0 (0) | |
| Diastolic function | |||
| E/e′ | 9.8 ± 2.9 | 5.4 ± 0.9 | < 0.0001 |
| E/e′ 8–12 | 19 (50) | 0 (0) | |
| E/e′ > 12 | 8 (21) | 0 (0) | |
| E/A | 1.8 ± 0.5 | – | |
| E/A ≥ 2 | 13 (34) | – | |
| TR jet (m/s) | 1.7 ± 1.3 | – | |
| Integrated backscatter | |||
| postcIB | −21 ± 4 | – | |
| sepcIB | −24 ± 8 | – | |
| avcIB (dB) | −22 ± 6 | – | |
| avcIB > −15 dB | 7 (18) | – | |
| PCWP (mmHg) | 13.8 ± 4.1 | 8.6 ± 1.46 | 0.0003 |
| PCWP > 15 | 15 (39) | 0 (0) | |
|
| |||
| Correlations | r | R2 | p |
|
| |||
| E/e′ – avcIB | 0.4481 | 0.2 | 0.005 |
| EF – avcIB | −0.3458 | 0.12 | 0.033 |
| EF – E/e′ | −0.2934 | 0.086 | 0.07 |
Data reported as mean ± SD or n (%).
EF = ejection fraction. E/e′ = ratio of E-wave to e′. E/A = ratio of early and late LV diastolic filling velocity. TR jet = tricuspid regurgitation velocity. postcIB = calibrated integrated backscatter of the posterior LV wall. sepcIB = calibrated integrated backscatter of septal LV wall. avcIB = average calibrated integrated backscatter of septal and posterior LV wall. PCWP = pulmonary capillary wedge pressure (calculated via the Nagueh-formula: PCWP = 1.24 * (E/e′) + 1.9; Nagueh et al. 1997). E/A, TR jet, and integrated backscatter were not assessed in the control group.
Figure 1Distribution of long-term systolic function, diastolic function, and myocardial fibrosis in pediatric burn survivors
EF = ejection fraction. E/e′ = ratio of E wave to e′—preload-independent index of LV compliance. avcIB = average calibrated integrated backscatter of myocardial septum and posterior LV wall.
Figure 2Long-term echocardiographic and functional data in pediatric burn survivors
a: Ejection fraction (EF%). Burn: 52 ± 9.1; Control: 61 ± 6.1; *p < 0.01. b: Diastolic function (E/e′). Burn: 9.8 ± 2.9; Control: 5.4 ± 0.9; ****p < 0.0001. c: Oxygen consumption (VO2) adjusted to body weight at rest and under peak treadmill exercise. Peak: Burn, 37.9 ± 12 ml/min/kg; Control, 46 ± 8.32 ml/min/kg; *p < 0.05. d: Heart rate (bpm) at rest and under peak treadmill exercise. Peak: Burn, 161 ± 26; Control, 182 ± 13; **p < 0.01.
Multivariable regression models of proinflammatory cytokines, catecholamines and cortisol for long-term outcomes
| Long-term event | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| EF < 50% | EF < 40% | E/e′ > 8 | avcIB | |||||
|
| ||||||||
| Estimate | p | Estimate | p | Estimate | p | Estimate | p | |
| Model [IL-1b, TNFα, IL-6, IL-8] | ||||||||
| Acute, maximum concentration | ||||||||
| Intercept | −0.98 | 0.212 | −2.12 | 0.223 | −1.97 | 0.0502 | ||
| IL-1P | 0.0183 | 0.556 | 0.00266 | 0.651 | −0.0897 | 0.204 | ||
| IL-6 | 0.00144 | 0.193 | −0.000452 | 0.554 | 0.00141 | 0.0407 | ||
| IL-8 | −0.000487 | 0.299 | 0.0168 | 0.0542 | ||||
| TNFα | 0.0156 | 0.392 | −0.0169 | 0.408 | −0.00367 | 0.221 | ||
|
| ||||||||
| R2 | 0.438 | 0.596 | 0.427 | |||||
|
| ||||||||
| Model [IL-1b, TNFα, IL-6, IL-8] | ||||||||
| Acute, mean concentration | ||||||||
| Intercept | −2.08 | 0.0506 | −2.09 | 0.0384 | −3.28 | 0.0867 | ||
| IL-1β | 0.055 | 0.544 | −0.0467 | 0.116 | −0.00811 | 0.824 | ||
| IL-6 | −0.000432 | 0.114 | −0.00138 | 0.502 | 0.000419 | 0.867 | ||
| IL-8 | 0.00525 | 0.754 | 0.0381 | 0.0196 | ||||
| TNFα | 0.121 | 0.122 | 0.167 | 0.0311 | −0.024 | 0.728 | ||
|
| ||||||||
| R2 | 0.494 | 0.356 | 0.633 | |||||
|
| ||||||||
| Model [epinephrine, cortisol] | ||||||||
| Acute, mean concentration | ||||||||
| Intercept | 0.257 | 0.805 | −0.536 | 0.67 | ||||
| Epinephrine | 0.00814 | 0.401 | 0.0104 | 0.448 | ||||
| Cortisol | −0.00511 | 0.211 | −0.00547 | 0.327 | ||||
|
| ||||||||
| R2 | 0.683 | 0.631 | ||||||
= Modeled without IL-8. Epinephrine and cortisol concentrations per 24h in urine, averaged over duration of acute hospitalization.